Nu Skin Enterprises, Inc.NUSNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank93
3Y CAGR+31.2%
5Y CAGR+6.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+31.2%/yr
vs -14.5%/yr prior
5Y CAGR
+6.7%/yr
Recent acceleration
Acceleration
+45.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM17.74%+489.8%
2024-4.55%-144.2%
202310.31%+31.1%
20227.86%-42.5%
202113.67%+6.4%
202012.84%-9.7%
201914.22%-3.5%
201814.73%-3.0%
201715.18%+10.5%
201613.75%-